Pulmonx (LUNG) News Today → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free LUNG Stock Alerts $9.00 +0.23 (+2.62%) (As of 12:20 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 4:55 AM | marketbeat.comVictory Capital Management Inc. Lowers Stock Position in Pulmonx Co. (NASDAQ:LUNG)Victory Capital Management Inc. decreased its position in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 10.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 853,846 shares of the company's stock after selling 96,917 shares during theMay 7, 2024 | americanbankingnews.comPulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of "Moderate Buy" by AnalystsMay 6, 2024 | globenewswire.comPulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)May 4, 2024 | finance.yahoo.comEarnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are Updating Their ForecastsMay 3, 2024 | finance.yahoo.comPulmonx First Quarter 2024 Earnings: Beats ExpectationsMay 3, 2024 | finance.yahoo.comPulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call TranscriptMay 2, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) PT Lowered to $15.00 at Canaccord Genuity GroupCanaccord Genuity Group cut their target price on shares of Pulmonx from $16.00 to $15.00 and set a "buy" rating for the company in a research report on Thursday.May 2, 2024 | markets.businessinsider.comAnalyst Recommendation Report Summary: Insights and Strategic Investment PerspectivesMay 2, 2024 | marketwatch.comPulmonx Surge After Strong 1Q PerformanceMay 2, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Announces Quarterly Earnings ResultsPulmonx (NASDAQ:LUNG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.36) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.07. The firm had revenue of $18.85 million for the quarter, compared to analysts' expectations of $17.54 million. Pulmonx had a negative return on equity of 46.63% and a negative net margin of 88.60%. During the same quarter in the previous year, the company earned ($0.42) earnings per share.May 2, 2024 | finance.yahoo.comQ1 2024 Pulmonx Corp Earnings CallMay 2, 2024 | finance.yahoo.comPulmonx Corp (LUNG) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and Improved ...May 1, 2024 | investorplace.comLUNG Stock Earnings: Pulmonx Beats EPS, Beats Revenue for Q1 2024May 1, 2024 | finance.yahoo.comPulmonx Corp (LUNG) Q1 2024 Earnings: Surpasses Revenue Estimates Amidst Continued LossesMay 1, 2024 | globenewswire.comPulmonx Reports First Quarter 2024 Financial ResultsApril 25, 2024 | finance.yahoo.comPulmonx Corporation (LUNG) Stock Price, News, Quote & History - Yahoo FinanceApril 10, 2024 | globenewswire.comPulmonx to Report First Quarter 2024 Financial Results on May 1, 2024April 4, 2024 | investing.comPulmonx names new CFO to bolster financial leadershipApril 3, 2024 | markets.businessinsider.comNavigating 6 Analyst Ratings For PulmonxApril 3, 2024 | marketbeat.comPiper Sandler Reaffirms "Overweight" Rating for Pulmonx (NASDAQ:LUNG)Piper Sandler reaffirmed an "overweight" rating and issued a $17.00 target price on shares of Pulmonx in a report on Wednesday.April 2, 2024 | marketwatch.comPulmonx Taps Mehul Joshi as Finance ChiefApril 2, 2024 | globenewswire.comPulmonx Announces Appointment of Mehul Joshi as Chief Financial OfficerMarch 30, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Short Interest UpdatePulmonx Co. (NASDAQ:LUNG - Get Free Report) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,040,000 shares, a drop of 17.5% from the February 29th total of 1,260,000 shares. Currently, 3.0% of the company's stock are short sold. Based on an average daily trading volume, of 458,900 shares, the short-interest ratio is presently 2.3 days.March 27, 2024 | insidertrades.comInsider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells 1,184 Shares of StockMarch 26, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Insider Sells $11,082.24 in StockPulmonx Co. (NASDAQ:LUNG - Get Free Report) insider Geoffrey Beran Rose sold 1,184 shares of the stock in a transaction that occurred on Friday, March 22nd. The shares were sold at an average price of $9.36, for a total value of $11,082.24. Following the completion of the sale, the insider now directly owns 307,868 shares of the company's stock, valued at $2,881,644.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.March 17, 2024 | ca.finance.yahoo.comLUNG Apr 2024 12.500 callMarch 16, 2024 | finanznachrichten.dePulmonx Corporation: Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 16, 2024 | marketbeat.comWalleye Capital LLC Takes Position in Pulmonx Co. (NASDAQ:LUNG)Walleye Capital LLC acquired a new stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 372,290 shares of the company's stock, valued at approximately $3,846,000.March 15, 2024 | globenewswire.comPulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)March 14, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 175,166 Shares of Pulmonx Co. (NASDAQ:LUNG)Jacobs Levy Equity Management Inc. cut its stake in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 25.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 505,379 shares of the companMarch 7, 2024 | marketbeat.comPulmonx Co. (NASDAQ:LUNG) Shares Sold by Deutsche Bank AGDeutsche Bank AG decreased its holdings in Pulmonx Co. (NASDAQ:LUNG - Free Report) by 91.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 46,868 shares of the company's stock after selling 490,932 shares during tMarch 5, 2024 | marketbeat.comFmr LLC Has $20.97 Million Stake in Pulmonx Co. (NASDAQ:LUNG)Fmr LLC lifted its position in shares of Pulmonx Co. (NASDAQ:LUNG - Free Report) by 24.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 2,029,835 shares of the company's stock after acquiring an additional 401,830 shares during the quarter. Fmr LLC owned aMarch 4, 2024 | ca.finance.yahoo.comLUNG Apr 2024 7.500 putMarch 4, 2024 | ca.finance.yahoo.comLUNG May 2024 7.500 putMarch 3, 2024 | finance.yahoo.comLUNG Aug 2024 10.000 putMarch 3, 2024 | finance.yahoo.comLUNG Apr 2024 10.000 callMarch 3, 2024 | finance.yahoo.comLUNG Aug 2024 20.000 callMarch 1, 2024 | finance.yahoo.comSteven Cohen's Point72 Asset Management Bolsters Position in Pulmonx CorpFebruary 26, 2024 | finanznachrichten.dePulmonx Corporation: Pulmonx Announces Treatment of the First Patient with the AeriSeal System in CONVERT II Pivotal TrialFebruary 26, 2024 | businesswire.comPulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal TrialFebruary 25, 2024 | msn.comPulmonx (LUNG) Price Target Increased by 7.61% to 16.83February 24, 2024 | finance.yahoo.comUS$16.50 - That's What Analysts Think Pulmonx Corporation (NASDAQ:LUNG) Is Worth After These ResultsFebruary 23, 2024 | msn.comWells Fargo Downgrades Pulmonx (LUNG)February 23, 2024 | msn.comPulmonx dips on Wells Fargo downgrade eyeing uncertainty over management changesFebruary 23, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Given New $17.00 Price Target at CitigroupCitigroup upped their price objective on Pulmonx from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Friday.February 23, 2024 | finance.yahoo.comPulmonx Full Year 2023 Earnings: Beats ExpectationsFebruary 23, 2024 | marketbeat.comPulmonx (NASDAQ:LUNG) Downgraded by Wells Fargo & Company to Equal WeightWells Fargo & Company cut shares of Pulmonx from an "overweight" rating to an "equal weight" rating and reduced their price target for the company from $16.00 to $14.00 in a research report on Friday.February 23, 2024 | realmoney.thestreet.comWells Fargo downgrades Pulmonx on management uncertaintyFebruary 23, 2024 | realmoney.thestreet.comPulmonx just downgraded at Wells Fargo, here's whyFebruary 22, 2024 | finanznachrichten.dePulmonx Corporation: Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely! Learn how this American company is leading the lithium-ion revolution LUNG Media Mentions By Week LUNG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LUNG News Sentiment▼1.100.57▲Average Medical News Sentiment LUNG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LUNG Articles This Week▼32▲LUNG Articles Average Week Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NeuroPace News Today Tactile Systems Technology News Today Cerus News Today Bioventus News Today Anika Therapeutics News Today Beauty Health News Today Pulse Biosciences News Today Nevro News Today OraSure Technologies News Today Fractyl Health News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LUNG) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
